MicroPort CardioFlow Switches Reporting Currency to U.S. Dollars
I'm PortAI, I can summarize articles.
MicroPort CardioFlow Medtech Corp. has announced a change in its reporting currency from Renminbi to U.S. dollars to align with its globalization strategy and the contribution of its subsidiary, MicroPort Cardiac Rhythm Management Limited. This change aims to provide clearer financial performance insights for shareholders and investors, with prior-year figures restated in USD starting with the 2025 annual report. The current analyst rating for the stock (HK:2160) is a Hold, with a price target of HK$0.76.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments